Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Djonlagic

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Critical Care Medicine|December 1, 2000
Effectiveness of end-tidal carbon dioxide tension for monitoring thrombolytic therapy in acute pulmonary embolismU K Wiegand, V Kurowski, E Giannitsis, et al.
Deutsche Medizinische Wochenschrift (1946)|May 7, 1982
[Pulmonary effect of inhaling leather-impregnation sprays (author's transl)]G Müller-Esch, E Brunk, H Djonlagic, et al.
Heart (British Cardiac Society)|June 1, 1997
Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarctionE Giannitsis, J Potratz, U Wiegand, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1991
Endocarditis caused by an unidentified gram-positive coccusS Gatermann, R Mitusch, H Djonlagic, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Bundle-of-His electrography during Brufacaine administration. Animal experiment studies]H Djonlagic, H Kircher, H A von Kurnatowski, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 1, 1994
[Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion]H Djonlagic, K Funke, J Lessmann, et al.
Japanese Heart Journal|January 1, 1996
Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinaseI Derad, U Stierle, E Giannitsis, et al.
Clinical Genetics|February 6, 2004
Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutationH Wedekind, M Schwarz, S Hauenschild, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Critical Care Medicine|December 1, 2000
Effectiveness of end-tidal carbon dioxide tension for monitoring thrombolytic therapy in acute pulmonary embolismU K Wiegand, V Kurowski, E Giannitsis, et al.
Deutsche Medizinische Wochenschrift (1946)|May 7, 1982
[Pulmonary effect of inhaling leather-impregnation sprays (author's transl)]G Müller-Esch, E Brunk, H Djonlagic, et al.
Heart (British Cardiac Society)|June 1, 1997
Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarctionE Giannitsis, J Potratz, U Wiegand, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1991
Endocarditis caused by an unidentified gram-positive coccusS Gatermann, R Mitusch, H Djonlagic, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Bundle-of-His electrography during Brufacaine administration. Animal experiment studies]H Djonlagic, H Kircher, H A von Kurnatowski, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 1, 1994
[Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion]H Djonlagic, K Funke, J Lessmann, et al.
Japanese Heart Journal|January 1, 1996
Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinaseI Derad, U Stierle, E Giannitsis, et al.
Clinical Genetics|February 6, 2004
Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutationH Wedekind, M Schwarz, S Hauenschild, et al.
Pageof 3